4-Chloro-Phthalimide

4-Chloro-Phthalimide

SCHEMBL658064

O=C1NC(=O)c2cc(Cl)ccc21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPOX P50336 1/20 1.00
MAOA P21397 3/20 0.63
MAOB P27338 3/20 0.63
RXFP1 Q9HBX9 2/20 0.58
PKM P14618 2/20 0.58
ATIC P31939 1/20 0.57
S100A4 P26447 2/20 0.56
CES1 P23141 2/20 0.55
TGM2 P21980 1/20 0.55
KDM4E B2RXH2 1/20 0.53
MAPT P10636 1/20 0.53
GSK3B P49841 1/20 0.50
CYP3A4 P08684 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
CHEK1 O14757 2/20 0.47
GRM5 P41594 1/20 0.47
DAPK3 O43293 1/20 0.47
MAP4K4 O95819 1/20 0.47
RET P07949 1/20 0.47
PIM1 P11309 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
4-Chloro-Phthalimide SCHEMBL30932877 1.00 PPOX (1.00) PPOXMAOAMAOBRXFP1PKM
4-Chloro-Phthalimide SCHEMBL31268124 0.98 PPOX (0.95) PPOXMAOAMAOBRXFP1PKM
SCHEMBL14486961 0.89 PPOX (0.80) PPOXMAOAMAOBRXFP1PKM
4-Chloro-Phthalimide SCHEMBL27477784 0.88 PPOX (0.78) PPOXMAOAMAOBRXFP1PKM
Diphenylether SCHEMBL27493914 0.84 MAOA (0.73) PPOXMAOAMAOBRXFP1PKM
Diphenylsulfane SCHEMBL27631759 0.84 MAOA (0.73) PPOXMAOAMAOBRXFP1PKM
SCHEMBL10401638 0.83 PPOX (0.70) PPOXMAOAMAOBRXFP1PKM
SCHEMBL8726573 0.83 PPOX (0.70) PPOXMAOAMAOBRXFP1PKM
SCHEMBL10600683 0.82 PPOX (0.69) PPOXMAOAMAOBRXFP1PKM
SCHEMBL31139641 0.79 CES1 (0.77) PPOXMAOAMAOBCES1TGM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 214 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4206205-B1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE BEIJING CO LTD (CN) 2026-03-04 EP claimed
CN-118165232-A Conjugated polymer based on isoindole-1, 3-dione [5,6] triazole and synthetic method and application thereof 河北大学 2024-06-11 CN claimed
CN-117567287-A Synthesis method of 2, 4-dichloro-5-nitrobenzoic acid 扬州市荣晶新材料科技有限公司 2024-02-20 CN claimed
US-20230303578-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND PRIMEGENE (BEIJING) CO., LTD. (CN) 2023-09-28 US claimed
EP-4206205-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND Primegene (Beijing) Co., Ltd. (CN) 2023-07-05 EP claimed
WO-2022042577-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND 北京普祺医药科技有限公司 2022-03-03 WO claimed
CN-108203836-B Method for improving deep plating capacity of electroplated copper 艾威尔电路(深圳)有限公司 2021-12-17 CN claimed
CN-108117645-B Method for preparing polyaryl imide and production device thereof 北京鼎益新材科技有限公司 2020-08-14 CN claimed
CN-108203836-A A kind of method for improving electro-coppering covering power 艾威尔电路(深圳)有限公司 2018-06-26 CN claimed
CN-108117645-A The poly- fragrant acid imide manufacturing method of one kind and its process units 梅雪 2018-06-05 CN claimed
EP-1235782-B1 METHOD FOR OXIDATION OF XYLENE DERIVATIVES GEN ELECTRIC (US) 2004-02-18 EP claimed
US-6465685-B1 SUCH AS CHLORO-O-XYLENE, ARE OXIDIZED IN A SOLVENT IN THE PRESENCE OF A METAL COMPOUND CATALYST WITH ADDITION OF PROMOTER AFTER THE REACTION HAS PROCEEDED TO AN INTERMEDIATE STAGE; PRODUCT COMPRISES CHLOROPHTHALIC ACID OR ANHYDRIDE GENERAL ELECTRIC COMPANY 2002-10-15 US claimed
EP-1235781-A1 METHOD FOR OXIDATION OF XYLENE DERIVATIVES GENERAL ELECTRIC COMPANY (US) 2002-09-04 EP claimed
EP-1235782-A1 METHOD FOR OXIDATION OF XYLENE DERIVATIVES GENERAL ELECTRIC COMPANY (US) 2002-09-04 EP claimed
US-6399790-B1 USING METAL CATALYST GENERAL ELECTRIC COMPANY 2002-06-04 US claimed
WO-2001038281-A1 METHOD FOR OXIDATION OF XYLENE DERIVATIVES GENERAL ELECTRIC COMPANY (US) 2001-05-31 WO claimed
WO-2001038282-A1 METHOD FOR OXIDATION OF XYLENE DERIVATIVES GENERAL ELECTRIC COMPANY (US) 2001-05-31 WO claimed
US-5132423-A Nucleophilic substitution reaction of alkali hydroxy- or mercaptoaromatic compound and heterocyclic substituted imide GENERAL ELECTRIC COMPANY (US) 1992-07-21 US claimed
US-4256507-A FLAVANTHRONE, PYRANTHRONE, INDANTHRONE, INDIGO, QUINACRIDONE, PERYLENE DIANHYDRIDE OR DIIMIDE PIGMENTS SUBSTITUTED WITH PHTHALIMIDO-METHYL GROUPS BASF AKTIENGESELLSCHAFT (DE) 1981-03-17 US claimed
US-4181530-A ELECTRON ATTRACTING PHTHALIMIDE FUJI PHOTO FILM CO., LTD. (JP) 1980-01-01 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303578-A1 PREPARATION METHOD FOR PYRROLOPYRIMIDINE COMPOUND DPYD, RPLP2, DHPS PPOX 27/4885MAOA 2270/4885MAOB 1120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.